secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001213900-24-040955
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08, 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics sets 2024 Annual Meeting for July 29, 2024; updates stockholder proposal deadlines
--------------------------------------------------------------------------------

- Annual Meeting scheduled for July 29, 2024; record date set as June 6, 2024.
- Stockholder proposals under Rule 14a-8 must be received by May 20, 2024.
- Director nominations and other proposals not included in proxy also due by May 20, 2024.
- Universal proxy rule compliance notice due by May 30, 2024 (60 days before meeting).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/0001213900-24-040955-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/ea020556601-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-040955

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer